Shivanshu Bajaj

Employment

Employment history is unavailable.

Education

• BITS Pilani PhD
  2020 - 2025
• Jamia Hamdard Faculty of Pharmacy M.Pharm
  2018 - 2020
• Maharshi Dayanand University B.Pharm
  2014 - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• Galantamine–Escitalopram Combination Therapy in Alzheimer’s Comorbid Depression Model in Mice: Role of BDNF/KYN Pathways, Neuroinflammation, and Oxidative Stress
  ACS Omega 2026 DOI: 10.1021/acsomega.5c08276
  +Save
• Galantamine as add-on therapy to escitalopram: enhancing antidepressant therapeutic potential via. Targeting α7nAChR/BDNF/KYN signalling
  Psychopharmacology 2026 DOI: 10.1007/s00213-025-06841-8
  +Save
• Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics
  Molecular Biology Reports 2024 DOI: 10.1007/s11033-023-09170-1
  +Save
• Effect of the MAGL/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer’s Disease-like Sporadic Dementia in Mice with an Emphasis on Aβ, HSP-70, Neuroinflammation, and Oxidative Stress
  ACS Chemical Neuroscience 2022 DOI: 10.1021/acschemneuro.1c00699
  +Save
• The role of endocannabinoid pathway in the neuropathology of Alzheimer’s disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer’s disease?
  Brain Research Bulletin 2021 DOI: 10.1016/j.brainresbull.2021.06.022
  +Save